Works matching IS 08876924 AND DT 2015 AND VI 29 AND IP 3

Results: 35

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.

Published in:

2015

By:

Pepper, C;
Buggins, A G S;
Jones, C H;
Walsby, E J;
Forconi, F;
Pratt, G;
Devereux, S;
Stevenson, F K;
Fegan, C

Publication type:

Letter

CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.

Published in:

2015

By:

Korthuis, P M;
Berger, G;
Bakker, B;
Rozenveld-Geugien, M;
Jaques, J;
de Haan, G;
Schuringa, J J;
Vellenga, E;
Schepers, H

Publication type:

journal article

In vitro expansion of CD34(+)CD38(-) cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.

Published in:

2015

By:

Sakashita, K;
Kato, I;
Daifu, T;
Saida, S;
Hiramatsu, H;
Nishinaka, Y;
Ebihara, Y;
Ma, F;
Matsuda, K;
Saito, S;
Hirabayashi, K;
Kurata, T;
Uyen, L T N;
Nakazawa, Y;
Tsuji, K;
Heike, T;
Nakahata, T;
Koike, K

Publication type:

journal article

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.

Published in:

2015

By:

Gerloff, D;
Grundler, R;
Wurm, A A;
Bräuer-Hartmann, D;
Katzerke, C;
Hartmann, J-U;
Madan, V;
Müller-Tidow, C;
Duyster, J;
Tenen, D G;
Niederwieser, D;
Behre, G

Publication type:

journal article

Classifying ultra-high risk smoldering myeloma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 751, doi. 10.1038/leu.2014.313

By:

Waxman, A J;
Mick, R;
Garfall, A L;
Cohen, A;
Vogl, D T;
Stadtmauer, E A;
Weiss, B M

Publication type:

Article

WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 660, doi. 10.1038/leu.2014.243

By:

Krauth, M-T;
Alpermann, T;
Bacher, U;
Eder, C;
Dicker, F;
Ulke, M;
Kuznia, S;
Nadarajah, N;
Kern, W;
Haferlach, C;
Haferlach, T;
Schnittger, S

Publication type:

Article

Reply to Passamonti et al: ruxolitinib and survival improvement in patients with myelofibrosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 740, doi. 10.1038/leu.2014.312

By:

Barosi, G;
Gale, R P

Publication type:

Article

In vitro expansion of CD34<sup>+</sup>CD38<sup>−</sup> cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 606, doi. 10.1038/leu.2014.239

By:

Sakashita, K;
Kato, I;
Daifu, T;
Saida, S;
Hiramatsu, H;
Nishinaka, Y;
Ebihara, Y;
Ma, F;
Matsuda, K;
Saito, S;
Hirabayashi, K;
Kurata, T;
Uyen, L T N;
Nakazawa, Y;
Tsuji, K;
Heike, T;
Nakahata, T;
Koike, K

Publication type:

Article

Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 548, doi. 10.1038/leu.2014.234

By:

Østgård, L S G;
Nørgaard, J M;
Sengeløv, H;
Severinsen, M;
Friis, L S;
Marcher, C W;
Dufva, I H;
Nørgaard, M

Publication type:

Article

Augmented efficacy with the combination of blockade of the Notch-1 pathway, bortezomib and romidepsin in a murine MT-1 adult T-cell leukemia model.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 556, doi. 10.1038/leu.2014.241

By:

Yu, P;
Petrus, M N;
Ju, W;
Zhang, M;
Conlon, K C;
Nakagawa, M;
Maeda, M;
Bamford, R N;
Waldmann, T A

Publication type:

Article

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 689, doi. 10.1038/leu.2014.219

By:

Ferrero, S;
Ladetto, M;
Drandi, D;
Cavallo, F;
Genuardi, E;
Urbano, M;
Caltagirone, S;
Grasso, M;
Rossini, F;
Guglielmelli, T;
Cangialosi, C;
Liberati, A M;
Callea, V;
Carovita, T;
Crippa, C;
De Rosa, L;
Pisani, F;
Falcone, A P;
Pregno, P;
Oliva, S

Publication type:

Article

Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 567, doi. 10.1038/leu.2014.267

By:

Niederwieser, C;
Kohlschmidt, J;
Volinia, S;
Whitman, S P;
Metzeler, K H;
Eisfeld, A-K;
Maharry, K;
Yan, P;
Frankhouser, D;
Becker, H;
Schwind, S;
Carroll, A J;
Nicolet, D;
Mendler, J H;
Curfman, J P;
Wu, Y-Z;
Baer, M R;
Powell, B L;
Kolitz, J E;
Moore, J O

Publication type:

Article

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 696, doi. 10.1038/leu.2014.236

By:

Waizenegger, J S;
Ben-Batalla, I;
Weinhold, N;
Meissner, T;
Wroblewski, M;
Janning, M;
Riecken, K;
Binder, M;
Atanackovic, D;
Taipaleenmaeki, H;
Schewe, D;
Sawall, S;
Gensch, V;
Cubas-Cordova, M;
Seckinger, A;
Fiedler, W;
Hesse, E;
Kröger, N;
Fehse, B;
Hose, D

Publication type:

Article

Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 647, doi. 10.1038/leu.2014.233

By:

Berlin, C;
Kowalewski, D J;
Schuster, H;
Mirza, N;
Walz, S;
Handel, M;
Schmid-Horch, B;
Salih, H R;
Kanz, L;
Rammensee, H-G;
Stevanović, S;
Stickel, J S

Publication type:

Article

The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 677, doi. 10.1038/leu.2014.264

By:

Vater, I;
Montesinos-Rongen, M;
Schlesner, M;
Haake, A;
Purschke, F;
Sprute, R;
Mettenmeyer, N;
Nazzal, I;
Nagel, I;
Gutwein, J;
Richter, J;
Buchhalter, I;
Russell, R B;
Wiestler, O D;
Eils, R;
Deckert, M;
Siebert, R

Publication type:

Article

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 741, doi. 10.1038/leu.2014.306

By:

Pardanani, A;
Abdelrahman, R A;
Finke, C;
Lasho, T T;
Begna, K H;
Al-Kali, A;
Hogan, W J;
Litzow, M R;
Hanson, C A;
Ketterling, R P;
Tefferi, A

Publication type:

Article

Phenotypic heterogeneity in IGHV-mutated CLL patients has prognostic impact and identifies a subset with increased sensitivity to BTK and PI3Kδ inhibition.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 744, doi. 10.1038/leu.2014.308

By:

Pepper, C;
Buggins, A G S;
Jones, C H;
Walsby, E J;
Forconi, F;
Pratt, G;
Devereux, S;
Stevenson, F K;
Fegan, C

Publication type:

Article

Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 586, doi. 10.1038/leu.2014.245

By:

Eiring, A M;
Page, B D G;
Kraft, I L;
Mason, C C;
Vellore, N A;
Resetca, D;
Zabriskie, M S;
Zhang, T Y;
Khorashad, J S;
Engar, A J;
Reynolds, K R;
Anderson, D J;
Senina, A;
Pomicter, A D;
Arpin, C C;
Ahmad, S;
Heaton, W L;
Tantravahi, S K;
Todic, A;
Colaguori, R

Publication type:

Article

MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 727, doi. 10.1038/leu.2014.279

By:

Jagannathan, S;
Vad, N;
Vallabhapurapu, S;
Anderson, K C;
Driscoll, J J

Publication type:

Article

Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 526, doi. 10.1038/leu.2014.229

By:

DeAngelo, D J;
Stevenson, K E;
Dahlberg, S E;
Silverman, L B;
Couban, S;
Supko, J G;
Amrein, P C;
Ballen, K K;
Seftel, M D;
Turner, A R;
Leber, B;
Howson-Jan, K;
Kelly, K;
Cohen, S;
Matthews, J H;
Savoie, L;
Wadleigh, M;
Sirulnik, L A;
Galinsky, I;
Neuberg, D S

Publication type:

Article

You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 517, doi. 10.1038/leu.2014.349

By:

Sehgal, A R;
Konig, H;
Johnson, D E;
Tang, D;
Amaravadi, R K;
Boyiadzis, M;
Lotze, M T

Publication type:

Article

CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 625, doi. 10.1038/leu.2014.259

By:

Korthuis, P M;
Berger, G;
Bakker, B;
Rozenveld-Geugien, M;
Jaques, J;
de Haan, G;
Schuringa, J J;
Vellenga, E;
Schepers, H

Publication type:

Article

FHL2 regulates hematopoietic stem cell functions under stress conditions.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 615, doi. 10.1038/leu.2014.254

By:

Hou, Y;
Wang, X;
Li, L;
Fan, R;
Chen, J;
Zhu, T;
Li, W;
Jiang, Y;
Mittal, N;
Wu, W;
Peace, D;
Qian, Z

Publication type:

Article

In vivo murine model of acquired resistance in myeloma reveals differential mechanisms for lenalidomide and pomalidomide in combination with dexamethasone.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 705, doi. 10.1038/leu.2014.238

By:

Ocio, E M;
Fernández-Lázaro, D;
San-Segundo, L;
López-Corral, L;
Corchete, L A;
Gutiérrez, N C;
Garayoa, M;
Paíno, T;
García-Gómez, A;
Delgado, M;
Montero, J C;
Díaz-Rodríguez, E;
Mateos, M V;
Pandiella, A;
Couto, S;
Wang, M;
Bjorklund, C C;
San-Miguel, J F

Publication type:

Article

Ruxolitinib and survival improvement in patients with myelofibrosis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 739, doi. 10.1038/leu.2014.282

By:

Passamonti, F;
Vannucchi, A M;
Cervantes, F;
Harrison, C;
Morra, E;
Kantarjian, H;
Verstovsek, S

Publication type:

Article

NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 535, doi. 10.1038/leu.2014.231

By:

Gerloff, D;
Grundler, R;
Wurm, A A;
Bräuer-Hartmann, D;
Katzerke, C;
Hartmann, J-U;
Madan, V;
Müller-Tidow, C;
Duyster, J;
Tenen, D G;
Niederwieser, D;
Behre, G

Publication type:

Article

Allogeneic and autologous stem cell transplantation for hepatosplenic T-cell lymphoma: a retrospective study of the EBMT Lymphoma Working Party.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 686, doi. 10.1038/leu.2014.280

By:

Tanase, A;
Schmitz, N;
Stein, H;
Boumendil, A;
Finel, H;
Castagna, L;
Blaise, D;
Milpied, N;
Sucak, G;
Sureda, A;
Thomson, K;
Vandenberghe, E;
Vitek, A;
Dreger, P

Publication type:

Article

Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 715, doi. 10.1038/leu.2014.255

By:

Yang, Y;
Chen, Y;
Saha, M N;
Chen, J;
Evans, K;
Qiu, L;
Reece, D;
Chen, G A;
Chang, H

Publication type:

Article

Cbfb deficiency results in differentiation blocks and stem/progenitor cell expansion in hematopoiesis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 753, doi. 10.1038/leu.2014.316

By:

Wang, C Q;
Chin, D W L;
Chooi, J Y;
Chng, W J;
Taniuchi, I;
Tergaonkar, V;
Osato, M

Publication type:

Article

Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 758, doi. 10.1038/leu.2014.309

By:

Bassaganyas, L;
Beà, S;
Escaramís, G;
Tornador, C;
Salaverria, I;
Zapata, L;
Drechsel, O;
Ferreira, P G;
Rodriguez-Santiago, B;
Tubio, J M C;
Navarro, A;
Martín-García, D;
López, C;
Martínez-Trillos, A;
López-Guillermo, A;
Gut, M;
Ossowski, S;
López-Otín, C;
Campo, E;
Estivill, X

Publication type:

Article

Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 636, doi. 10.1038/leu.2014.225

By:

Peng, Y;
Chen, X;
Liu, Q;
Zhang, X;
Huang, K;
Liu, L;
Li, H;
Zhou, M;
Huang, F;
Fan, Z;
Sun, J;
Ke, M;
Li, X;
Zhang, Q;
Xiang, A P

Publication type:

Article

A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 598, doi. 10.1038/leu.2014.252

By:

Queirós, A C;
Villamor, N;
Clot, G;
Martinez-Trillos, A;
Kulis, M;
Navarro, A;
Penas, E M M;
Jayne, S;
Majid, A;
Richter, J;
Bergmann, A K;
Kolarova, J;
Royo, C;
Russiñol, N;
Castellano, G;
Pinyol, M;
Bea, S;
Salaverria, I;
López-Guerra, M;
Colomer, D

Publication type:

Article

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 748, doi. 10.1038/leu.2014.311

By:

Sava, G P;
Speedy, H E;
Di Bernardo, M C;
Dyer, M J S;
Holroyd, A;
Sunter, N J;
Marr, H;
Mansouri, L;
Deaglio, S;
Karabon, L;
Frydecka, I;
Jamroziak, K;
Woszczyk, D;
Juliusson, G;
Smedby, K E;
Jayne, S;
Majid, A;
Wang, Y;
Dearden, C;
Hall, A G

Publication type:

Article

Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 668, doi. 10.1038/leu.2014.251

By:

Junlén, H R;
Peterson, S;
Kimby, E;
Lockmer, S;
Lindén, O;
Nilsson-Ehle, H;
Erlanson, M;
Hagberg, H;
Rådlund, A;
Hagberg, O;
Wahlin, B E

Publication type:

Article

Hes1 suppresses acute myeloid leukemia development through FLT3 repression.

Published in:

Leukemia (08876924), 2015, v. 29, n. 3, p. 576, doi. 10.1038/leu.2014.281

By:

Kato, T;
Sakata-Yanagimoto, M;
Nishikii, H;
Ueno, M;
Miyake, Y;
Yokoyama, Y;
Asabe, Y;
Kamada, Y;
Muto, H;
Obara, N;
Suzukawa, K;
Hasegawa, Y;
Kitabayashi, I;
Uchida, K;
Hirao, A;
Yagita, H;
Kageyama, R;
Chiba, S

Publication type:

Article